We are live on ! Find out more
FMTX

Forma Therapeutics Holdings, Inc. Common Stock
FMTX

Delisted

FMTX was delisted on the 13th of October, 2022.

Back to rankings

139 hedge funds and large institutions have $835M invested in Forma Therapeutics Holdings, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 58 funds opening new positions, 37 increasing their positions, 29 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

228% more capital invested

Capital invested by funds: $255M → $835M (+$580M)

142% more first-time investments, than exits

New positions opened: 58 | Existing positions closed: 24

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

78% more call options, than puts

Call options by funds: $20.1M | Put options by funds: $11.3M

32% more funds holding

Funds holding: 105 → 139 (+34)

28% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 29

Holders
139
Holders Change
+34
Holders Change %
+32.38%
% of All Funds
2.39%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.07%
New
58
Increased
37
Reduced
29
Closed
24
Calls
$20.1M
Puts
$11.3M
Net Calls
+$8.84M
Net Calls Change
+$9.38M

Top Buyers

Rank Fund Capital Flow
1
TAL
TIG Advisors LLC
New York
+$17.2M
2
WIC
Water Island Capital
New York
+$16.5M
3
AAM
Alpine Associates Management
Florida
+$15M
4
FTCM
First Trust Capital Management
Illinois
+$13.6M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$13.1M

Top Sellers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
-$40.7M
2
CAM
Cormorant Asset Management
Massachusetts
-$21.9M
3
EPL
EDBI Pte Ltd
Singapore
-$16M
4
Citadel Advisors
Citadel Advisors
Florida
-$14.3M
5
SB
Samsara BioCapital
California
-$6.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
51
Bank of New York Mellon
New York
$2.51M +$285K +21,616 +21%
WMSA
52
Weiss Multi-Strategy Advisers
New York
$2.23M +$1.47M +111,524 New
CS
53
Credit Suisse
Switzerland
$2.2M +$1.29M +97,581 +759%
AI
54
Arena Investors
New York
$2.15M +$1.42M +107,913 New
HM
55
Harvest Management
New York
$2M +$1.32M +100,000 New
VAM
56
Vazirani Asset Management
New York
$2M +$1.32M +100,000 New
Macquarie Group
57
Macquarie Group
Australia
$1.86M – – –
N
58
Natixis
France
$1.78M +$1.18M +89,400 New
CC
59
Centiva Capital
New York
$1.7M +$985K +74,668 +723%
Ameriprise
60
Ameriprise
Minnesota
$1.68M +$1.11M +84,424 New
Swiss National Bank
61
Swiss National Bank
Switzerland
$1.56M – – –
Verition Fund Management
62
Verition Fund Management
Connecticut
$1.5M +$993K +75,260 New
Two Sigma Advisers
63
Two Sigma Advisers
New York
$1.49M -$1.15M -87,300 -54%
Invesco
64
Invesco
Georgia
$1.32M -$24.7K -1,872 -3%
BHMP
65
Bardin Hill Management Partners
New York
$1.32M +$872K +66,085 New
RhumbLine Advisers
66
RhumbLine Advisers
Massachusetts
$1.3M +$81.9K +6,213 +11%
BFM
67
Boothbay Fund Management
New York
$1.26M +$832K +63,089 New
EPL
68
EDBI Pte Ltd
Singapore
$1.11M -$16M -1,212,950 -96%
CS
69
Candriam SCA
Luxembourg
$1.08M -$3.15M -238,580 -82%
Marshall Wace
70
Marshall Wace
United Kingdom
$1.01M +$219K +16,631 +49%
VF
71
Virtu Financial
New York
$1.01M +$670K +50,773 New
PI
72
Putnam Investments
Massachusetts
$1M +$665K +50,399 New
Walleye Capital
73
Walleye Capital
New York
$997K +$659K +49,979 New
BCM
74
BCK Capital Management
Connecticut
$878K +$580K +44,000 New
Barclays
75
Barclays
United Kingdom
$871K +$395K +29,980 +220%
1 2
3
4 5

FMTX Hedge Fund Activity: Q3 2022 in Review

139 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Forma Therapeutics Holdings, Inc. Common Stock (FMTX) for Q3 2022, worth a combined $835M — up 228% from $255M a quarter earlier.

Buyers outnumbered sellers: 58 funds opened new FMTX positions and 24 closed out — a net gain of 34 holders — while 37 added to existing stakes and 29 trimmed.

The largest buyer was TIG Advisors LLC, opening a new position worth an estimated $17.2M. The largest seller was Deep Track Capital, cutting an estimated $40.7M.

  • 139 institutional investors held Forma Therapeutics Holdings, Inc. Common Stock (FMTX) as of Q3 2022, up from 105 in Q2 2022.
  • Funds reported $835M of Forma Therapeutics Holdings, Inc. Common Stock stock for Q3 2022, up 228% quarter-over-quarter.
  • 58 funds opened new Forma Therapeutics Holdings, Inc. Common Stock positions in Q3 2022 and 24 closed out, a net change of +34 holders.
  • The largest Forma Therapeutics Holdings, Inc. Common Stock buyer in Q3 2022 was TIG Advisors LLC, an estimated $17.2M added.
  • The largest Forma Therapeutics Holdings, Inc. Common Stock seller in Q3 2022 was Deep Track Capital, an estimated $40.7M sold.

Based on aggregated 13F filings for Q3 2022.